Business · 31/01/2001

FDA Releases Draft Guidance on Pre-Storage Leukocyte Reduction of Blood Components

The Food and Drug Administration (FDA) has made available a draft document outlining recommendations for the manufacturing and quality assurance of blood components intended for transfusion, with the goal of reducing leukocytes in whole blood and blood components before storage.